We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$174M
AUM Growth
+$15.3M
Cap. Flow
+$869K
Cap. Flow %
0.5%
Top 10 Hldgs %
22.23%
Holding
180
New
23
Increased
31
Reduced
71
Closed
28

Top Buys

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$1.79M
2
J icon
Jacobs Solutions
J
+$1.54M
3
AMGN icon
Amgen
AMGN
+$1.42M
4
PB icon
Prosperity Bancshares
PB
+$1.37M
5
LNG icon
Cheniere Energy
LNG
+$1.33M

Top Sells

Rank Stock Value
1
DE icon
Deere & Co
DE
+$1.42M
2
FANG icon
Diamondback Energy
FANG
+$1.32M
3
VLO icon
Valero Energy
VLO
+$1.14M
4
EOG icon
EOG Resources
EOG
+$1.04M
5
ARW icon
Arrow Electronics
ARW
+$945K

Sector Composition

Rank Sector Weight
1 Industrials 22.1%
2 Healthcare 18.51%
3 Consumer Staples 13.38%
4 Financials 13.17%
5 Technology 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
76
Costco
COST
$400B
$902K 0.52%
1,975
+1,350
+216% +$660K
SLB icon
77
SLB Ltd
SLB
$80.4B
$902K 0.52%
16,867
-7,134
-30% -$355K
INVH icon
78
Invitation Homes
INVH
$16.3B
$899K 0.52%
30,319
DE icon
79
Deere & Co
DE
$184B
$885K 0.51%
2,065
-3,495
-63% -$1.42M
GWW icon
80
W.W. Grainger
GWW
$59.8B
$807K 0.46%
+1,450
New +$818K
CMA
81
DELISTED
Comerica
CMA
$774K 0.44%
+11,575
New +$802K
CHRW icon
82
C.H. Robinson
CHRW
$18.4B
$756K 0.43%
+8,253
New +$786K
GSK icon
83
GSK
GSK
$100B
$745K 0.43%
21,200
-4,840
-19% -$161K
DD icon
84
DuPont de Nemours
DD
$17.3B
$741K 0.43%
8,604
-491
-5% -$39.2K
CFR icon
85
Cullen/Frost Bankers
CFR
$10.1B
$739K 0.42%
5,525
-800
-13% -$114K
TKR icon
86
Timken Company
TKR
$8.08B
$705K 0.41%
+9,975
New +$697K
VZ icon
87
Verizon
VZ
$214B
$702K 0.4%
17,815
-850
-5% -$32K
CL icon
88
Colgate-Palmolive
CL
$69.4B
$696K 0.4%
8,838
JPM icon
89
JPMorgan Chase
JPM
$937B
$684K 0.39%
5,098
-2,737
-35% -$347K
GIS icon
90
General Mills
GIS
$19.6B
$681K 0.39%
8,125
ETN icon
91
Eaton
ETN
$152B
$659K 0.38%
+4,200
New +$644K
TDG icon
92
TransDigm Group
TDG
$60B
$658K 0.38%
1,045
IR icon
93
Ingersoll Rand
IR
$27.9B
$645K 0.37%
12,350
SBUX icon
94
Starbucks
SBUX
$110B
$620K 0.36%
6,245
TD icon
95
Toronto Dominion Bank
TD
$199B
$606K 0.35%
9,350
-1,825
-16% -$118K
AWK icon
96
American Water Works
AWK
$27.4B
$602K 0.35%
3,950
HLT icon
97
Hilton Worldwide
HLT
$69.3B
$599K 0.34%
4,740
-6,660
-58% -$878K
MHK icon
98
Mohawk Industries
MHK
$8.74B
$582K 0.33%
5,695
-855
-13% -$83.8K
ALB icon
99
Albemarle
ALB
$13.4B
$580K 0.33%
+2,675
New +$713K
AMZN icon
100
Amazon
AMZN
$2.68T
$580K 0.33%
6,900
+1,425
+26% +$141K

Similar funds

New England Research & Management's Q4 2022 Portfolio in Review

As of Q4 2022, New England Research & Management held 180 positions worth $174M, up 9.6% from $159M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q4 2022 filing shows 23 new, 31 increased, 71 reduced and 28 closed positions. Its largest new stake was Amgen: 5,280 shares worth $1.39M. The largest sale was Deere & Co, an estimated $1.42M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q4 2022 buy was Amgen: 5,280 shares worth $1.39M.
  • New England Research & Management added most to EQT Corp in Q4 2022, an estimated $1.79M increase.
  • New England Research & Management's biggest Q4 2022 reduction was Deere & Co, cutting an estimated $1.42M.
  • New England Research & Management fully exited Diamondback Energy in Q4 2022, selling an estimated $1.32M.
  • New England Research & Management's ten largest holdings make up 22% of its $174M portfolio in Q4 2022.
  • New England Research & Management opened 23 new positions and closed 28 in Q4 2022.
  • New England Research & Management's portfolio value rose 9.6% quarter-over-quarter to $174M.

Based on New England Research & Management's 13F filing for Q4 2022, filed 9 Jan 2023.